In this single-centre , phase 2 , prospective , randomised , open-label , blinded end-point evaluation study , adults with supratentorial ischaemic stroke eligible for intravenous thrombolysis within 45 h of onset were recruited from The Institute of Neurological Sciences , Glasgow , Scotland .